AIMERGING HEALTH
AIMERGING HEALTH is a French société par actions simplifiée (SAS), registered with the French business registry under SIREN 839175106 (SIRET 839 175 106 00013). The company was incorporated on 27 April 2018, with its registered office at 35 Rue Berger, 75001 Paris, France, and share capital of €10,000.
The company was classified under NAF/APE code 5829C, «Édition de logiciels applicatifs» (application software publishing). According to the company’s own public presentation, AIMERGING HEALTH — trading under the name A.I.Merging Health — developed artificial-intelligence-based software tools for preventive and predictive healthcare applications, intended for institutions and private-sector organisations operating in e-health and risk-related areas of medicine. This activity description reflects the company’s own stated positioning rather than an independently audited business description.
AIMERGING HEALTH’s registration record shows a cessation-of-activity notice dated 5 February 2025, and the company was recorded as closed on 21 May 2025. No annual accounts appear to have been filed with the French registry, so no revenue or employee figures are available for AIMERGING HEALTH. The company does not appear to have been listed on any stock exchange.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
2
Shareholders of AIMERGING HEALTH
On-file shareholder data shows AIMERGING HEALTH’s €10,000 share capital divided equally between two named individuals, both recorded with a data verification date of 10 August 2026: Olivier Ami, holding one ordinary share valued at €5,100 (50% of capital), and Jean-Christophe Maran, holding one ordinary share valued at €4,900 (50% of capital). No independent French-registry filing setting out this shareholding split (such as a Bodacc capital-transaction notice) was located during this research; the position is presented as reported by the data source rather than independently re-verified against a primary filing.
Ultimate beneficial ownership
No dedicated Registre des Bénéficiaires Effectifs (RBE) filing was located for AIMERGING HEALTH during this research. Olivier Ami and Jean-Christophe Maran are each recorded as direct 50% shareholders, which would ordinarily exceed common beneficial-ownership disclosure thresholds; however, this profile does not present either individual as a confirmed UBO in the absence of a located RBE filing or another authoritative source making that determination.
Data availability
Shareholder disclosure for this entity is treated as Full based on the on-file registry-linked shareholder record, since both holders and their percentage interests are stated. AIMERGING HEALTH was recorded as dissolved on 21 May 2025, so this shareholding position should be read as historical rather than reflecting a currently operating company.
Sources
- Societe.com, company page for AIMERGING HEALTH (SIREN 839175106) — https://www.societe.com/societe/aimerging-health-839175106.html — retrieved 17 September 2026.
- Pappers.fr, company page for AIMERGING HEALTH (SIREN 839175106), citing INSEE/RNE registry data — https://www.pappers.fr/entreprise/aimerging-health-839175106 — retrieved 17 September 2026.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Olivier Ami | 50% | INPI (Institut National de la Propriété Industrielle) | |
| Jean-Christophe Maran | 50% | INPI (Institut National de la Propriété Industrielle) |
Officers
4
Directors and officers of AIMERGING HEALTH
Two individuals held officer roles at AIMERGING HEALTH throughout its registered life: Olivier Ami as President and Jean-Christophe Maran as Directeur Général (General Director / Chief Executive Officer). Both were appointed on incorporation, with terms recorded by external registry sources as running from 1 May 2018 to 21 May 2025, the date the company was recorded as dissolved; both are accordingly treated as former rather than current officers. The on-file officer records include duplicate entries for the same two individuals carrying inconsistent status flags, which reflects successive registry snapshots rather than additional personnel.
Recent officer changes
AIMERGING HEALTH’s dissolution, recorded on 21 May 2025 and preceded by a cessation-of-activity filing dated 5 February 2025, ended both Olivier Ami’s presidency and Jean-Christophe Maran’s role as Directeur Général. No other appointments, resignations or role changes were identified.
Data availability
Officer information for this SAS is treated as Full for the two named individuals, including role and appointment/end dates, sourced from French registry-linked data. Nationality is Not disclosed in any source reviewed for this research. The correspondence locations on file (Paris for Olivier Ami; Créteil for Jean-Christophe Maran) are service/correspondence details only and are not evidence of either individual’s nationality or country of residence.
Sources
- Societe.com, company page for AIMERGING HEALTH (SIREN 839175106) — https://www.societe.com/societe/aimerging-health-839175106.html — retrieved 17 September 2026.
- Pappers.fr, company page for AIMERGING HEALTH (SIREN 839175106), citing INSEE/RNE registry data — https://www.pappers.fr/entreprise/aimerging-health-839175106 — retrieved 17 September 2026.
Group Structure
Group structure of AIMERGING HEALTH
No parent company, subsidiary or other verified corporate-group relationship has been identified for AIMERGING HEALTH. The on-file corporate-linkage data explicitly records no parent, subsidiary or ownership link for this entity, consistent with a small, independently operated single-entity structure rather than a documented corporate group. AIMERGING HEALTH was recorded as dissolved on 21 May 2025.
Data availability
Not found: no reliable evidence of a corporate-group relationship was located for AIMERGING HEALTH through the French registry sources or company materials reviewed for this research. This reflects an absence of located evidence rather than confirmation that no such relationship has ever existed.
Sources
- Societe.com, company page for AIMERGING HEALTH (SIREN 839175106) — https://www.societe.com/societe/aimerging-health-839175106.html — retrieved 17 September 2026.
- Pappers.fr, company page for AIMERGING HEALTH (SIREN 839175106), citing INSEE/RNE registry data — https://www.pappers.fr/entreprise/aimerging-health-839175106 — retrieved 17 September 2026.
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
What is AIMERGING HEALTH's SIREN number?
AIMERGING HEALTH is registered under SIREN 839175106 with the French business registry.
What is AIMERGING HEALTH's SIRET number?
The SIRET number for AIMERGING HEALTH's registered establishment is 839 175 106 00013.
What does AIMERGING HEALTH do?
AIMERGING HEALTH, trading as A.I.Merging Health, developed artificial-intelligence-based software tools for preventive and predictive healthcare applications, intended for institutions and private-sector organisations in e-health and risk-related areas of medicine, according to the company's own public presentation.
When was AIMERGING HEALTH incorporated?
AIMERGING HEALTH was incorporated on 27 April 2018, according to French registry-linked sources.
Where is AIMERGING HEALTH registered?
AIMERGING HEALTH was registered in Paris, France, with its registered office at 35 Rue Berger, 75001 Paris.
What is AIMERGING HEALTH's legal form?
AIMERGING HEALTH was a société par actions simplifiée (SAS), a French simplified joint-stock company.
Is AIMERGING HEALTH still active?
No. AIMERGING HEALTH recorded a cessation of activity on 5 February 2025 and was closed/dissolved on 21 May 2025.
Who are AIMERGING HEALTH's shareholders?
On-file data records two shareholders: Olivier Ami (50%) and Jean-Christophe Maran (50%), each holding one ordinary share.
Who was the President of AIMERGING HEALTH?
Olivier Ami served as President of AIMERGING HEALTH from the company's incorporation until its dissolution on 21 May 2025.
Who was the Chief Executive Officer of AIMERGING HEALTH?
Jean-Christophe Maran served as Directeur Général (General Director / CEO) of AIMERGING HEALTH from incorporation until the company's dissolution on 21 May 2025.
Does AIMERGING HEALTH have a parent company or subsidiaries?
No verified parent company, subsidiary or other corporate-group relationship has been identified for AIMERGING HEALTH.
What is AIMERGING HEALTH's NAF/APE code?
AIMERGING HEALTH was classified under NAF/APE code 5829C, application software publishing, with a stated focus on healthcare software.
What was AIMERGING HEALTH's share capital?
AIMERGING HEALTH's share capital was €10,000.
Is AIMERGING HEALTH listed on a stock exchange?
No. AIMERGING HEALTH does not appear to have been listed on any stock exchange.
What is AIMERGING HEALTH's registered address?
AIMERGING HEALTH's registered office was at 35 Rue Berger, 75001 Paris, France.